Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Abdominal Radiology (New York)
|
July 12, 2017
Preoperative CT in patients with surgically resectable pancreatic adenocarcinoma: does the time interval between CT and surgery affect survival?
Gerard M Healy, C E Redmond, S Murphy, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
April 11, 2012
Invasive markers identified by gene expression profiling in pancreatic cancer
A Rogers, M J Smith, P Doolan, et al.
European Journal of Gastroenterology & Hepatology
|
August 18, 2020
A novel value-based scoring system for endoscopic ultrasound-guided drainage of pancreatic fluid collections: a single-centre comparative study of plastic and lumen-apposing metal stents (NOVA study)
Vikrant Parihar, Yasir Basir, Deirdre Nally, et al.
Irish Journal of Medical Science
|
July 25, 2014
Pancreatic metastasectomy: experience of the Irish National Surgical Centre for Pancreatic Cancer
C E Redmond, H Adler, H M Heneghan, et al.
Blood
|
October 1, 1991
Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a
J W Smith, D L Longo, W J Urba, et al.
Journal of the National Cancer Institute
|
January 18, 1995
A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2
J T Holmund, W C Kopp, R H Wiltrout, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2
B D Curti, D L Longo, A C Ochoa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1992
The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies
J W Smith, W J Urba, B D Curti, et al.
Blood
|
March 27, 2001
A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma
J E Janik, L L Miller, E L Korn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1996
Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancer
B L Gause, M Sznol, W C Kopp, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Abdominal Radiology (New York)
|
July 12, 2017
Preoperative CT in patients with surgically resectable pancreatic adenocarcinoma: does the time interval between CT and surgery affect survival?
Gerard M Healy, C E Redmond, S Murphy, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
April 11, 2012
Invasive markers identified by gene expression profiling in pancreatic cancer
A Rogers, M J Smith, P Doolan, et al.
European Journal of Gastroenterology & Hepatology
|
August 18, 2020
A novel value-based scoring system for endoscopic ultrasound-guided drainage of pancreatic fluid collections: a single-centre comparative study of plastic and lumen-apposing metal stents (NOVA study)
Vikrant Parihar, Yasir Basir, Deirdre Nally, et al.
Irish Journal of Medical Science
|
July 25, 2014
Pancreatic metastasectomy: experience of the Irish National Surgical Centre for Pancreatic Cancer
C E Redmond, H Adler, H M Heneghan, et al.
Blood
|
October 1, 1991
Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a
J W Smith, D L Longo, W J Urba, et al.
Journal of the National Cancer Institute
|
January 18, 1995
A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2
J T Holmund, W C Kopp, R H Wiltrout, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2
B D Curti, D L Longo, A C Ochoa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1992
The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies
J W Smith, W J Urba, B D Curti, et al.
Blood
|
March 27, 2001
A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma
J E Janik, L L Miller, E L Korn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1996
Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancer
B L Gause, M Sznol, W C Kopp, et al.
Page
of 10